Follow The Filings

CRS Carpenter Technology Corporation

Industrials, filed as CARPENTER TECHNOLOGY CORP (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 7 managers in 2026 Q2

  • 6 Owners
  • #249
  • Max 13.7%
  • Master 0.07%
  • $1.2B
  • 6 reduce

In 2026 Q2, 6 managers trimmed.

Who owns this now

Largest portfolio weights among holders, up to 13.7% (Mala Gaonkar, Surgocap Partners). Not free-float ownership.

  1. Mala Gaonkar Reduce 13.7%
  2. Stephen Mandel Reduce 3.6%
  3. Dan Loeb Reduce 2.8%
  4. Polen Capital Management Reduce 0.04%
  5. George Soros Reduce 0.03%

Who owns CRS

Sorted by value, long equity only, as of 2026 Q2.

History
Stephen Mandel, Lone Pine Capital 3.6%, was 5.7% Reduce −47.0% 962,839 $594M History
Mala Gaonkar, Surgocap Partners 13.7%, was 15.8% Reduce −42.6% 686,473 $423M History
Dan Loeb, Third Point 2.8%, was 5.9% Reduce −30.6% 215,000 $133M History
Polen Capital Management 0.04% Reduce −45.7% 6,756 $4.2M History
George Soros, Soros Fund Management 0.03% Reduce −48.9% 4,308 $2.7M History
Cathie Wood, Ark Investment Management <0.01% Reduce −29.6% 178 $110K History

6 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CRS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CRS insider trades
  • None no insider bought on the open market
  • $94.6M sold by 8 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Steven E Karol Director
    Sale
    $1.6M 3,275 shares at $474.08 1.8% of stake
    Traded Sep 4 Filed Sep 9
    ↗
  2. Tony R Thene CEO
    Sale
    $52.9M 109,283 shares at $483.84
    Traded Aug 25 Filed Aug 27
    ↗
  3. Ramin Younessi Director
    Sale
    $216K 438 shares at $493.15 18% of stake
    Traded Aug 21 Filed Aug 25
    ↗
  4. Steven E Karol Director
    Sale
    $975K 2,000 shares at $487.74 0.9% of stake
    Traded Jun 1 Filed Jun 3
    ↗
  5. Anastasios John Hart Director
    Sale
    $115K 250 shares at $461.88 100% of stake
    Traded May 28 Filed Jun 1
    ↗
  6. Marshall D Akins VP and Chief Comm Officer
    Sale
    $5.2M 11,815 shares at $441.36 39% of stake
    Traded May 5 Filed May 6
    ↗
  7. Anastasios John Hart Director
    Sale
    $318K 750 shares at $423.86 100% of stake
    Traded May 4 Filed May 6
    ↗
  8. James D Dee SVP, Gen Counsel & Sec
    Sale
    $6.2M 15,800 shares at $391.78 18% of stake
    Traded Feb 24 Filed Feb 25
    ↗
  9. Steven E Karol Director
    Sale
    $2.5M 6,500 shares at $380.60
    Traded Feb 19 Filed Feb 23
    ↗
  10. Brian J Malloy COO
    Sale
    $23M 75,458 shares at $304.82 49% of stake
    Traded Dec 9–11 Filed Dec 11, 2025
    ↗
  11. Elizabeth A Socci VP, Contr & Ch Acctg Officer
    Sale
    $1.3M 3,900 shares at $321.25 29% of stake
    Traded Nov 26, 2025 Filed Dec 1, 2025
    ↗
  12. Ramin Younessi Director
    Sale
    $399K 1,300 shares at $307.19 31% of stake
    Traded Nov 21, 2025 Filed Nov 25, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 12 share withholdings for taxes, 12 option exercises, 11 stock grants, and 5 gifts.

Congress

1 member of Congress traded CRS in the last three years: 3 buys and 0 sales.

All Congress trades
  1. Markwayne Mullin R-OKJoint Buy $15K–$50K Feb 4 filed Mar 2
  2. Markwayne Mullin R-OK Buy $15K–$50K Jan 5 filed Feb 4
  3. Markwayne Mullin R-OKSpouse Buy $15K–$50K Jan 5 filed Feb 4

SEC filings

Recent issuer filings from EDGAR, 13 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
DEF 14A Filing Doc
8-K 7.01,9.01 Filing Doc
10-K Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 2 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue $2.55B $2.76B $2.88B $3.12B
Gross profit $337.3M $584.3M $768.6M $955.5M
Gross margin * 13.2% 21.2% 26.7% 30.6%
Net income $56.4M $186.5M $376M $529.8M
Net margin * 2.2% 6.8% 13.1% 17.0%

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $1.28B $1.59B $1.76B $1.98B
Total non-current assets * $1.77B $1.7B $1.72B $1.86B
Total assets $3.05B $3.29B $3.49B $3.84B
Total current liabilities $459.4M $466.3M $483.7M $520M
Total non-current liabilities * $1.2B $1.2B $1.12B $1.09B
Total equity $1.4B $1.63B $1.89B $2.23B

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations $14.7M $274.9M $440.4M $605M
Cash from investing -$82.3M -$95.9M -$152.9M -$242.7M
Cash from financing -$40.1M -$23.3M -$167.1M -$286.8M
Net change in cash -$109.7M $154.6M $116.4M $77.8M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.